Epigenetic Targeting of Aberrant Transcriptional Modulation in Pancreatic Cancer

Abstract excerpt

While the mortality rates of cancer are generally declining, pancreatic cancer persists to be an exception with a 5-year-survival rate of less than 7%. Late diagnosis and resistance to conventional therapies contribute to high mortality rates in spite of the remarkable recent advances in cancer management and research. Consequently, there is an urgent need to find new and unconventional therapeutic targets to impr...

Topics

Open a Topic to create a Post that cites this publication.

• Benzamides
• Cancer Genomics and Diagnostics
• Epigenetics and DNA Methylation
• Histone Deacetylase Inhibitors Research
• Lung Cancer Research Studies
• Neuroendocrine Tumor Research Advances
• Pancreatic and Hepatic Oncology Research
• Pancreatic function and diabetes

Identifiers and source

Literature Corpus work

375dbf5b-d4ea-53e7-90dc-393c7474a7e8

DOI

10.20944/preprints201805.0129.v1